Sweden · Delayed Price · Currency is SEK SenzaGen AB Statistics
Total Valuation
SenzaGen AB has a market cap or net worth of SEK 162.54 million. The enterprise value is 143.85 million.
| Market Cap | 162.54M |
| Enterprise Value | 143.85M |
Important Dates
The last earnings date was Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SenzaGen AB has 32.51 million shares outstanding. The number of shares has decreased by -4.07% in one year.
| Current Share Class | 32.51M |
| Shares Outstanding | 32.51M |
| Shares Change (YoY) | -4.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 24.95% |
| Owned by Institutions (%) | 20.95% |
| Float | 24.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.66 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 3.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.90 |
| Quick Ratio | 2.64 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.49 |
| Interest Coverage | -8.96 |
Financial Efficiency
Return on equity (ROE) is -11.13% and return on invested capital (ROIC) is -12.15%.
| Return on Equity (ROE) | -11.13% |
| Return on Assets (ROA) | -4.76% |
| Return on Invested Capital (ROIC) | -12.15% |
| Return on Capital Employed (ROCE) | -8.44% |
| Weighted Average Cost of Capital (WACC) | 7.19% |
| Revenue Per Employee | 1.80M |
| Profits Per Employee | -272,088 |
| Employee Count | 34 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 6.53 |
Taxes
| Income Tax | -359,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.57% in the last 52 weeks. The beta is 0.58, so SenzaGen AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -18.57% |
| 50-Day Moving Average | 5.35 |
| 200-Day Moving Average | 5.57 |
| Relative Strength Index (RSI) | 33.19 |
| Average Volume (20 Days) | 15,603 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SenzaGen AB had revenue of SEK 61.05 million and -9.25 million in losses. Loss per share was -0.31.
| Revenue | 61.05M |
| Gross Profit | 39.10M |
| Operating Income | -8.66M |
| Pretax Income | -9.61M |
| Net Income | -9.25M |
| EBITDA | -1.80M |
| EBIT | -8.66M |
| Loss Per Share | -0.31 |
Balance Sheet
The company has 35.52 million in cash and 16.83 million in debt, with a net cash position of 18.69 million or 0.57 per share.
| Cash & Cash Equivalents | 35.52M |
| Total Debt | 16.83M |
| Net Cash | 18.69M |
| Net Cash Per Share | 0.57 |
| Equity (Book Value) | 89.88M |
| Book Value Per Share | 2.76 |
| Working Capital | 39.62M |
Cash Flow
In the last 12 months, operating cash flow was -5.11 million and capital expenditures -1.64 million, giving a free cash flow of -6.75 million.
| Operating Cash Flow | -5.11M |
| Capital Expenditures | -1.64M |
| Depreciation & Amortization | 6.86M |
| Net Borrowing | -5.24M |
| Free Cash Flow | -6.75M |
| FCF Per Share | -0.21 |
Margins
Gross margin is 64.04%, with operating and profit margins of -14.19% and -15.15%.
| Gross Margin | 64.04% |
| Operating Margin | -14.19% |
| Pretax Margin | -15.74% |
| Profit Margin | -15.15% |
| EBITDA Margin | -2.95% |
| EBIT Margin | -14.19% |
| FCF Margin | n/a |
Dividends & Yields
SenzaGen AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.07% |
| Shareholder Yield | 4.07% |
| Earnings Yield | -5.69% |
| FCF Yield | -4.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SenzaGen AB has an Altman Z-Score of 1.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.24 |
| Piotroski F-Score | 4 |